Xylem (NYSE:XYL) Releases FY 2022 Earnings Guidance

Xylem (NYSE:XYLGet Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided EPS guidance of $2.40-$2.70 for the period, compared to the consensus EPS estimate of $2.54. The company issued revenue guidance of $5.25 billion-$5.35 billion, compared to the consensus revenue estimate of $5.31 billion.

Shares of Xylem stock traded down $0.23 during trading on Monday, reaching $84.98. 1,380,921 shares of the company traded hands, compared to its average volume of 1,439,255. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.62 and a quick ratio of 1.77. Xylem has a 1-year low of $80.00 and a 1-year high of $138.78. The company has a 50 day moving average price of $85.63 and a 200-day moving average price of $104.11. The firm has a market capitalization of $15.30 billion, a PE ratio of 36.63, a P/E/G ratio of 2.78 and a beta of 1.08.

Xylem (NYSE:XYLGet Rating) last released its earnings results on Wednesday, May 4th. The industrial products company reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.06. Xylem had a net margin of 8.10% and a return on equity of 13.80%. The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter in the previous year, the company earned $0.56 EPS. Xylem’s quarterly revenue was up 1.3% compared to the same quarter last year. Equities research analysts expect that Xylem will post 2.54 earnings per share for the current year.

A number of research analysts recently issued reports on XYL shares. Stifel Nicolaus dropped their target price on shares of Xylem from $100.00 to $90.00 and set a hold rating on the stock in a research report on Monday, April 18th. Mizuho lowered their price objective on shares of Xylem from $115.00 to $85.00 in a report on Friday. StockNews.com began coverage on shares of Xylem in a report on Thursday, March 31st. They set a hold rating for the company. TheStreet lowered shares of Xylem from a b rating to a c+ rating in a report on Monday, February 7th. Finally, Morgan Stanley cut their price target on Xylem from $120.00 to $110.00 and set an overweight rating for the company in a research note on Monday, April 18th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Hold and an average target price of $112.20.

In related news, SVP Colin R. Sabol sold 4,233 shares of the stock in a transaction that occurred on Monday, April 18th. The stock was sold at an average price of $83.05, for a total transaction of $351,550.65. Following the completion of the sale, the senior vice president now directly owns 27,373 shares of the company’s stock, valued at $2,273,327.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.89% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the stock. Deutsche Bank AG increased its position in shares of Xylem by 1.7% during the fourth quarter. Deutsche Bank AG now owns 1,198,452 shares of the industrial products company’s stock valued at $143,719,000 after acquiring an additional 20,522 shares during the last quarter. California State Teachers Retirement System grew its holdings in Xylem by 1.6% during the fourth quarter. California State Teachers Retirement System now owns 323,159 shares of the industrial products company’s stock valued at $38,753,000 after purchasing an additional 5,094 shares during the period. Barclays PLC grew its holdings in Xylem by 5.2% during the fourth quarter. Barclays PLC now owns 237,369 shares of the industrial products company’s stock valued at $28,466,000 after purchasing an additional 11,642 shares during the period. Stifel Financial Corp grew its holdings in Xylem by 0.9% during the fourth quarter. Stifel Financial Corp now owns 99,274 shares of the industrial products company’s stock valued at $11,906,000 after purchasing an additional 863 shares during the period. Finally, Metropolitan Life Insurance Co NY grew its holdings in Xylem by 2.3% during the fourth quarter. Metropolitan Life Insurance Co NY now owns 25,925 shares of the industrial products company’s stock valued at $3,109,000 after purchasing an additional 591 shares during the period. 83.83% of the stock is owned by institutional investors.

Xylem Company Profile (Get Rating)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

Read More

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.